WO2002052954A3 - Nutritional composition for a bone condition - Google Patents
Nutritional composition for a bone condition Download PDFInfo
- Publication number
- WO2002052954A3 WO2002052954A3 PCT/EP2002/000296 EP0200296W WO02052954A3 WO 2002052954 A3 WO2002052954 A3 WO 2002052954A3 EP 0200296 W EP0200296 W EP 0200296W WO 02052954 A3 WO02052954 A3 WO 02052954A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- bone condition
- nutritional composition
- composition
- zinc
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 210000000988 bone and bone Anatomy 0.000 title abstract 3
- 235000016709 nutrition Nutrition 0.000 title abstract 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 2
- 229930003316 Vitamin D Natural products 0.000 abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 2
- 229930003448 Vitamin K Natural products 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 235000001465 calcium Nutrition 0.000 abstract 2
- 229910052749 magnesium Inorganic materials 0.000 abstract 2
- 239000011777 magnesium Substances 0.000 abstract 2
- 235000001055 magnesium Nutrition 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 235000019166 vitamin D Nutrition 0.000 abstract 2
- 239000011710 vitamin D Substances 0.000 abstract 2
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 2
- 235000019168 vitamin K Nutrition 0.000 abstract 2
- 239000011712 vitamin K Substances 0.000 abstract 2
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 2
- 229940046008 vitamin d Drugs 0.000 abstract 2
- 229940046010 vitamin k Drugs 0.000 abstract 2
- 239000011701 zinc Substances 0.000 abstract 2
- 229910052725 zinc Inorganic materials 0.000 abstract 2
- 235000016804 zinc Nutrition 0.000 abstract 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- 229920001202 Inulin Polymers 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 229960005069 calcium Drugs 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 1
- 229940029339 inulin Drugs 0.000 abstract 1
- 229940091250 magnesium supplement Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000003687 soy isoflavones Nutrition 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
A nutritional composition is described for prevention or treatment of a bone condition. It comprises, in a broad definition, at least calcium, magnesium, zinc, vitamin D and vitamin K. For example, in an embodiment it comprises per 300 g: about 800 mg calcium, about 210 mg magnesium, about 15 mg zinc, about 10 ug vitamin D, about 60 ug vitamin K, about 1.5 mg copper, about 5 mg vitamin E, about 30 mg vitamin C, about 90 mg soy isoflavone and about 6 g inulin/FOS (30:70) blend. A method for making the composition; use of it in the manufacture of a functional food or medicament; and a method of prevention or treatment of a bone condition which comprises administering an effective amount of the composition are described.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02702265A EP1351584A2 (en) | 2001-01-08 | 2002-01-08 | Nutritional composition for a bone condition |
| AU2002235836A AU2002235836A1 (en) | 2001-01-08 | 2002-01-08 | Nutritional composition for a bone condition |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0100273.2A GB0100273D0 (en) | 2001-01-08 | 2001-01-08 | Nutritional composition for a bone condition |
| GB0100273.2 | 2001-01-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2002052954A2 WO2002052954A2 (en) | 2002-07-11 |
| WO2002052954A3 true WO2002052954A3 (en) | 2002-10-31 |
Family
ID=9906309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2002/000296 WO2002052954A2 (en) | 2001-01-08 | 2002-01-08 | Nutritional composition for a bone condition |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1351584A2 (en) |
| AU (1) | AU2002235836A1 (en) |
| GB (1) | GB0100273D0 (en) |
| WO (1) | WO2002052954A2 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0027761D0 (en) * | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
| FR2858181B1 (en) * | 2003-07-30 | 2008-02-29 | Christian Fenioux | HYPERPROTEINED FOOD PREPARATION COMPRISING AT LEAST ONE POLYPHENOL |
| US8663679B2 (en) | 2004-04-29 | 2014-03-04 | Abbott Laboratories | Compositions for improving breast health in women |
| MX2007001128A (en) * | 2004-07-28 | 2007-04-17 | Abbott Lab | Nutritional compositions and methods for treating or preventing osteoporosis. |
| US7601370B2 (en) | 2004-07-28 | 2009-10-13 | Abbott Laboratories | Method for controlling body weight in estrogen-insufficient women |
| US7435431B2 (en) | 2004-07-28 | 2008-10-14 | Abbott Laboratories | Method for controlling body weight in estrogen-insufficient women |
| DE102005033630A1 (en) * | 2005-07-19 | 2007-01-25 | Humana Gmbh | Calcium-peptide component |
| DE102006052915A1 (en) * | 2006-07-28 | 2008-01-31 | Humana Gmbh | Composition, useful in pharmaceutical products to treat diarrhea and as dietary products to promote intestinal health, comprises polyphenol and milk-peptide |
| DE102006052560B4 (en) * | 2006-11-06 | 2010-01-21 | Humana Milchunion Eg | Anti-diabetogenic calcium peptide composition |
| US20080118603A1 (en) * | 2006-11-21 | 2008-05-22 | Lada Mark W | Nutritional beverage for optimal bone health |
| WO2009040088A1 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of peptide kvlpvpq as a therapeutic agent |
| EP2230940B1 (en) * | 2007-12-05 | 2014-08-20 | N.V. Nutricia | High energy liquid enteral nutritional composition |
| NL1034964C2 (en) * | 2008-01-28 | 2009-07-30 | Friesland Brands Bv | Method and compositions for the treatment of bone disorders. |
| CN102065709A (en) * | 2008-06-19 | 2011-05-18 | 纽迪希亚公司 | Nutritional composition for bariatric surgery patients |
| CN102131405B (en) | 2008-06-19 | 2014-06-11 | 纽迪希亚公司 | Liquid nutritional composition for bariatric surgery patients |
| RU2011128132A (en) * | 2009-01-23 | 2013-02-27 | ВАЙЕТ ЭлЭлСи | FOOD ADDITIVES FOR PERSONS AGE 50 YEARS AND OLDER TO INCREASE VITALITY, IMMUNITY, HEALTH OF EYES AND BONES |
| EP2292102A1 (en) * | 2009-09-02 | 2011-03-09 | Lipofoods, S.L. | Microcapsules containing salts for food products |
| FR2963725B1 (en) * | 2010-08-16 | 2013-01-18 | Holymark | FOOD COMPOSITION FOR PREVENTING AND LIMITING MUSCLE MASS LOSS, LOSS OF BONE MINERAL DENSITY AND COGNITIVE DECLINE, PARTICULARLY IN ELDERLY PERSONS 50 YEARS OF AGE OR OVER |
| CN104472708A (en) * | 2014-11-26 | 2015-04-01 | 东北农业大学 | Milk powder capable of preventing and treating woman climacteric syndrome diseases and preparation method of milk powder |
| CN107853702A (en) * | 2017-11-03 | 2018-03-30 | 广州彤博士健康科技有限公司 | Compound micro-crystal powder formula and preparation method thereof |
| CN115399473A (en) * | 2021-05-27 | 2022-11-29 | 深圳市回春堂健康管理服务有限公司 | Yak marrow high-calcium protein powder composition for increasing bone density and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0721742A1 (en) * | 1995-01-13 | 1996-07-17 | Clintec Nutrition Company, An Illinois Partnership | Nutrition for elderly patients |
| US5827526A (en) * | 1995-07-11 | 1998-10-27 | Abbott Laboratories | Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans |
| WO1999026491A1 (en) * | 1997-11-24 | 1999-06-03 | Bristol-Myers Squibb Company | Fortified confectionery delivery systems and methods of preparation thereof |
| WO1999053777A1 (en) * | 1998-04-22 | 1999-10-28 | Novartis Nutrition Ag | Nutritional supplement for pregnant and lactating women |
| US5985339A (en) * | 1996-11-22 | 1999-11-16 | Kamarei; A. Reza | Refrigeration-shelf-stable ready-to-drink complete nutritional compositions and products |
-
2001
- 2001-01-08 GB GBGB0100273.2A patent/GB0100273D0/en not_active Ceased
-
2002
- 2002-01-08 EP EP02702265A patent/EP1351584A2/en not_active Withdrawn
- 2002-01-08 AU AU2002235836A patent/AU2002235836A1/en not_active Abandoned
- 2002-01-08 WO PCT/EP2002/000296 patent/WO2002052954A2/en not_active Application Discontinuation
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0721742A1 (en) * | 1995-01-13 | 1996-07-17 | Clintec Nutrition Company, An Illinois Partnership | Nutrition for elderly patients |
| US5827526A (en) * | 1995-07-11 | 1998-10-27 | Abbott Laboratories | Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans |
| US5985339A (en) * | 1996-11-22 | 1999-11-16 | Kamarei; A. Reza | Refrigeration-shelf-stable ready-to-drink complete nutritional compositions and products |
| WO1999026491A1 (en) * | 1997-11-24 | 1999-06-03 | Bristol-Myers Squibb Company | Fortified confectionery delivery systems and methods of preparation thereof |
| WO1999053777A1 (en) * | 1998-04-22 | 1999-10-28 | Novartis Nutrition Ag | Nutritional supplement for pregnant and lactating women |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002235836A1 (en) | 2002-07-16 |
| WO2002052954A2 (en) | 2002-07-11 |
| EP1351584A2 (en) | 2003-10-15 |
| GB0100273D0 (en) | 2001-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002052954A3 (en) | Nutritional composition for a bone condition | |
| WO2002052959A3 (en) | Beverage compositions comprising palatable calcium and magnesium sources | |
| WO2000003684A3 (en) | Soy formulations and their use for promoting health | |
| NO20032129D0 (en) | Nutritional composition for the immune system | |
| WO2002024002A3 (en) | Food supplement | |
| WO2003084342A3 (en) | Method and dietary composition for improving lipid digestibility | |
| WO2007022344A3 (en) | Methods and compositions for the preventioin and treatment of kidney disease | |
| WO2002080708A3 (en) | A smoker's requisite | |
| PL366049A1 (en) | Nutritional composition | |
| WO2007002836A3 (en) | Methods and compositions for the prevention and treatment of kidney disease | |
| WO2005065669A8 (en) | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision | |
| AU7566601A (en) | Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases | |
| WO2005094234A3 (en) | Dietary supplement for treating digestive system disorders | |
| AU2001275159A1 (en) | Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins | |
| AU4073901A (en) | Novel pharmaceutical or dietetic mushroom-based compositions | |
| WO2001089319A3 (en) | Tryptophan source from plants and uses therefor | |
| WO2003013270A3 (en) | Calcium dietary supplement | |
| WO2004100826A3 (en) | Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals | |
| WO2002026221A3 (en) | Method and composition for supplementation of nutritional deficiencies in renal patients | |
| WO2004039326A3 (en) | Propofol with cysteine | |
| AU773079C (en) | Immunopotentiating compositions | |
| MXPA02011465A (en) | Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same. | |
| WO2003049687A3 (en) | Medicinal compositions & therapeutic methods | |
| TNSN03043A1 (en) | 2h-1 benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof | |
| WO2002098442A3 (en) | Composition containing phytase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2002702265 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 2002702265 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 2002702265 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |